COMMUNIQUÉS West-GlobeNewswire

Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026 Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union, and the United [...]
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
13/05/2026
Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and development Manufacturing divestiture and expanded monetization of ZYNYZ royalty anticipated to provide up to $202.5 [...]
aTyr Pharma to Participate in Upcoming Investor Conferences
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
13/05/2026
Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million Emrosi ® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash position increased to $27 [...]
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
13/05/2026
Phase 3 CATT1 completion of enrollment on track for the third quarter of 2026 Strong balance sheet expected to fund operations through anticipated CATT1 topline data readout HIGH POINT, N.C., May 13, 2026 (GLOBE [...]
Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
13/05/2026
Phase 1 proof-of-mechanism study of EQ504 on track to initiate in mid-2026, with data expected approximately six months thereafter Equillium appoints Snehal Naik, Ph.D., as Chief Development Officer to lead clinical [...]
LogicMark, Inc. Announces Strong First Quarter 2026 Results
13/05/2026
Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows LOUISVILLE, Ky., May 13, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the “Company”), a provider of personal safety and emergency [...]
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
13/05/2026
100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study FDA Orphan Drug designation granted to tegoprubart for the [...]
Glass House Brands Reports First Quarter 2026 Financial Results
13/05/2026
First quarter results include revenue of $40.5 million, average selling price of $171 per pound and biomass production of 152,000 pounds Company reiterates full year 2026 wholesale cannabis biomass production forecast [...]
Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
13/05/2026
New Drug Application (NDA) for tebipenem HBr for complicated urinary tract infections (cUTI), including pyelonephritis, is under review at the FDA, with PDUFA date of June 18, 2026 Spero maintains its cash runway [...]
Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
13/05/2026
On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for hypoplastic left heart syndrome, a rare pediatric disease and orphan- [...]
Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
13/05/2026
Planned Interim Futility Analysis from Pivotal Phase 2 ALPHA3 Trial Supports Cemacabtagene Ansegedleucel’s (Cema-Cel) Potential as an Outpatient, MRD-Guided Consolidation Therapy in 1L Large B-cell Lymphoma (LBCL) 58.3 [...]
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
13/05/2026
REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for [...]
JavaTide Claims Evaluated: Investigating the Java Tide Ingredients for Purity and Potency
13/05/2026
JavaTide Prebiotic and Probiotic Weight Loss Support: Chicory Root Inulin, Resistant Starch, and Akkermansia muciniphila for Gut Health and Metabolism Explained Largo, FL, May 13, 2026 (GLOBE NEWSWIRE) -- These [...]
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2025 et présente un point sur ses activités
13/05/2026
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2025 ET LES EVENEMENTS CLEFS DE LA PERIODE Situation financière et corporate Déficit opérationnel de 3,8 millions d’euros au 31 [...]
Assemblée Générale Annuelle d’Ipsen S.A. du 13 mai 2026
13/05/2026
Assemblée Générale Annuelle d’Ipsen S.A. du 13 mai 2026 Toutes les résolutions soumises au vote des actionnaires ont été adoptées PARIS, FRANCE, 13 MAI 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd'hui que [...]
AB Science reports its revenues for the year 2025 and provides an update on its activities
13/05/2026
PRESS RELEASE AB SCIENCE PRESENTS ITS ANNUAL FINANCIAL RESULTS AS OF 31 DECEMBER 2025 AND KEY EVENTS FOR THE PERIOD Financial and corporate position Operating loss of €3.8 million as of 31 December 2025, down 38% [...]
Chengdu Origen and Vanotech Announce KHN921 Investigational New Drug application clearance by the US FDA for the treatment of hypertrophic cardiomyopathy (HCM) associated with MYBPC3 mutations
13/05/2026
Investigational New Drug application for KHN921 received “study may proceed” from the US FDA. KHN921 is a potential "first-in-class" cardiovascular AAV gene therapy being developed for the treatment of hypertrophic [...]
MAPS Announces Dates for Psychedelic Science 2027; Early Bird Registrations Now Open
13/05/2026
Early bird registration is now open for Psychedelic Science 2027, taking place May 3–7, 2027, in Denver, Colorado. Early bird pricing offers discounted registration in limited quantities to the world’s leading [...]

Pages